ReviewDrug safety2020

Safety of Eosinophil-Depleting Therapy for Severe, Eosinophilic Asthma: Focus on Benralizumab.

David J Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.